ReportsWeb- Human Immunodeficiency Virus Worldwide Market by V

Human Immunodeficiency Virus Worldwide Market by Value, Drug
Class, Brand, Region, Analysis 2017 and Forecast to 2021
ReportsWeb.com published “Human Immunodeficiency Virus Market” from its database. The
report covers the market landscape and its growth prospects over the coming years. The report
also includes a discussion of the key vendors operating in this market.
The report "Global HIV Market: Industry Analysis & Outlook (2017-2021) " by Publisher provides
an extensive research and detailed analysis of the present market along with future outlook. The
report discusses the major growth drivers and challenges of the market, covering the U.S along
with the global market. The report profiles players of the market including Johnson & Johnson,
Merck and Co., Gilead and GlaxoSmithKline Plc.
HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the
CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in
the body and makes the immune system vulnerable to life-threatening infections and cancers.
An infected person cannot get rid of this virus properly but its effects can be reduced with the
treatment.
For more information about this report: http://www.reportsweb.com/global-human-
immunodeficiency-virus-market-industry-analysis-and-outlook-2017-2021
HIV does not get spread easily into human. Only certain body fluids of an infected person can
transmit HIV into others. HIV never gets transmitted through casual contacts like handshakes,
sharing food or water. It has certain transmission ways including blood transmission of an
infected person to non-infected person, exchange of body fluids like semen, pre-seminal or
vaginal fluids during unprotected physical contacts and from a mother to child during
pregnancy or breastfeeding.
HIV therapeutics market is likely to witness a growth with increasing demand for single tablet
regimens and growth of HIV diagnostic market is expected to be driven by increasing
technological advancements in diagnosis tests.
Middle East and Africa are the major contributors to the global HIV market supported by
increased prevalence of HIV due to rising drug abuse and unprotected physical contacts among
adolescents. Asia-Pacific is likely to experience further growth of HIV market due to recent
development in HIV treatments.